GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (NSE:RPGLIFE) » Definitions » Cyclically Adjusted Revenue per Share

RPG Life Sciences (NSE:RPGLIFE) Cyclically Adjusted Revenue per Share : ₹304.58 (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

RPG Life Sciences's adjusted revenue per share for the three months ended in Mar. 2025 was ₹86.532. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹304.58 for the trailing ten years ended in Mar. 2025.

During the past 12 months, RPG Life Sciences's average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of RPG Life Sciences was 8.70% per year. The lowest was 8.20% per year. And the median was 8.45% per year.

As of today (2025-06-02), RPG Life Sciences's current stock price is ₹2181.20. RPG Life Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹304.58. RPG Life Sciences's Cyclically Adjusted PS Ratio of today is 7.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of RPG Life Sciences was 9.41. The lowest was 1.60. And the median was 3.23.


RPG Life Sciences Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for RPG Life Sciences's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences Cyclically Adjusted Revenue per Share Chart

RPG Life Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 221.81 237.16 258.47 280.65 304.58

RPG Life Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 280.65 289.75 298.38 303.88 304.58

Competitive Comparison of RPG Life Sciences's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RPG Life Sciences's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's Cyclically Adjusted PS Ratio falls into.


;
;

RPG Life Sciences Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RPG Life Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=86.532/157.5517*157.5517
=86.532

Current CPI (Mar. 2025) = 157.5517.

RPG Life Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 40.087 99.841 63.259
201509 40.688 101.753 63.000
201512 43.490 102.901 66.588
201603 41.665 102.518 64.031
201606 40.614 105.961 60.388
201609 46.633 105.961 69.338
201612 40.157 105.196 60.143
201703 41.967 105.196 62.854
201706 45.544 107.109 66.993
201709 54.189 109.021 78.311
201712 57.818 109.404 83.263
201803 50.745 109.786 72.823
201806 48.459 111.317 68.586
201809 54.885 115.142 75.101
201812 54.960 115.142 75.203
201903 37.723 118.202 50.281
201906 56.873 120.880 74.127
201909 59.579 123.175 76.207
201912 57.028 126.235 71.175
202003 49.716 124.705 62.811
202006 55.435 127.000 68.771
202009 58.714 130.118 71.093
202012 65.047 130.889 78.297
202103 52.619 131.771 62.914
202106 65.371 134.084 76.812
202109 68.091 135.847 78.970
202112 69.917 138.161 79.730
202203 60.943 138.822 69.165
202206 77.950 142.347 86.276
202209 81.538 144.661 88.804
202212 79.003 145.763 85.393
202303 69.383 146.865 74.432
202306 89.336 150.280 93.659
202309 92.882 151.492 96.597
202312 92.937 152.924 95.749
202403 76.810 153.035 79.077
202406 100.018 155.789 101.150
202409 104.149 157.882 103.931
202412 104.426 158.323 103.917
202503 86.532 157.552 86.532

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


RPG Life Sciences  (NSE:RPGLIFE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

RPG Life Sciences's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2181.20/304.58
=7.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of RPG Life Sciences was 9.41. The lowest was 1.60. And the median was 3.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


RPG Life Sciences Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


RPG Life Sciences Business Description

Industry
Traded in Other Exchanges
Address
463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines